BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26179544)

  • 1. Pathological Renal Findings of Chronic Renal Failure in a Patient with the E66Q Mutation in the α-galactosidase A Gene.
    Satomura A; Fujita T; Nakayama T; Kusano H; Takayama E; Hamada H; Maruyama T
    Intern Med; 2015; 54(14):1819-24. PubMed ID: 26179544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the α-galactosidase A gene.
    Kobayashi M; Ohashi T; Fukuda T; Yanagisawa T; Inomata T; Nagaoka T; Kitagawa T; Eto Y; Ida H; Kusano E
    Mol Genet Metab; 2012 Dec; 107(4):711-5. PubMed ID: 23146289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients.
    Doi K; Noiri E; Ishizu T; Negishi K; Suzuki Y; Hamasaki Y; Honda K; Fujita T; Tsukimura T; Togawa T; Saito S; Sakuraba H
    J Hum Genet; 2012 Sep; 57(9):575-9. PubMed ID: 22695894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.
    Oikawa M; Sakamoto N; Kobayashi A; Suzuki S; Yoshihisa A; Yamaki T; Nakazato K; Suzuki H; Saitoh S; Kiko Y; Nakano H; Hayashi T; Kimura A; Takeishi Y
    BMC Cardiovasc Disord; 2016 May; 16():83. PubMed ID: 27160240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of Fabry disease with the E66Q variant in the α-galactosidase A gene in Japanese dialysis patients: a case report and a literature review.
    Kikumoto Y; Sugiyama H; Morinaga H; Inoue T; Takiue K; Kitagawa M; Saito D; Takatori Y; Kinomura M; Kitamura S; Akagi S; Sada K; Nakao K; Maeshima Y; Kitayama H; Makino H
    Clin Nephrol; 2012 Sep; 78(3):224-9. PubMed ID: 22874111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease: biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution.
    Togawa T; Tsukimura T; Kodama T; Tanaka T; Kawashima I; Saito S; Ohno K; Fukushige T; Kanekura T; Satomura A; Kang DH; Lee BH; Yoo HW; Doi K; Noiri E; Sakuraba H
    Mol Genet Metab; 2012 Apr; 105(4):615-20. PubMed ID: 22305854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.
    Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S
    Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α-galactosidase A activity: A 14-year follow-up without enzyme replacement therapy.
    Odani K; Okumi M; Honda K; Ishida H; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():57-9. PubMed ID: 26971403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
    Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
    Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.
    Chong Y; Kim M; Koh ES; Shin SJ; Kim HS; Chung S
    BMC Med Genet; 2016 Oct; 17(1):76. PubMed ID: 27776503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine.
    Maruyama H; Takata T; Tsubata Y; Tazawa R; Goto K; Tohyama J; Narita I; Yoshioka H; Ishii S
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):629-36. PubMed ID: 23307880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
    Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
    Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the p.E66Q variant of GLA in the progression of chronic kidney disease.
    Watanabe H; Goto S; Miyashita A; Maruyama H; Wakasugi M; Yokoseki A; Kuwano R; Narita I
    Clin Exp Nephrol; 2015 Apr; 19(2):225-30. PubMed ID: 24718812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and cardiovascular features of Japanese hemodialysis patients with Fabry disease.
    Fujii H; Kono K; Goto S; Onishi T; Kawai H; Hirata K; Hattori K; Nakamura K; Endo F; Fukagawa M
    Am J Nephrol; 2009; 30(6):527-35. PubMed ID: 19844084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonsense mutation (R220X) in the alpha-galactosidase A gene causes typical Fabry disease in both genders.
    Maki N; Komatsuda A; Wakui H; Oyama Y; Kodama T; Ohtani H; Kigawa A; Aiba N; Imai H; Motegi M; Yamaguchi A; Sawada K
    Clin Nephrol; 2004 Mar; 61(3):185-90. PubMed ID: 15077869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
    Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
    Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry disease with cardiovascular manifestation in a patient with end-stage renal disease.
    Skopcová H; Dostálová G; Paleček T; Linhart A; Honsová E
    Cesk Patol; 2021; 57(1):49-52. PubMed ID: 33910349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Fabry's disease with granulomatous interstitial nephritis.
    Hiraizumi Y; Kanoh M; Shigematsu H; Yamashina M; Kondo T
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):655-61. PubMed ID: 8583703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A missense mutation of the α-galactosidase A gene in a Chinese family of Fabry disease with renal failure.
    Wang C; Wang Y; Zhu F; Xiong J
    Kidney Blood Press Res; 2013; 37(4-5):221-8. PubMed ID: 23867994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease.
    Wakakuri H; Nakamura S; Utsumi K; Shimizu W; Yasutake M
    Int Heart J; 2016 Sep; 57(5):637-9. PubMed ID: 27593536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.